European Commission (EC) Approves Henlius and Organon's POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe

SHANGHAI, China & JERSEY CITY, N.J.--(BUSINESS WIRE)--European Commission approves Henlius and Organon's POHERDY® (pertuzumab), the first approved Biosimilar to PERJETA (pertuzumab) in Europe.